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Binding of the HIV envelope to the chemokine
coreceptors triggers membrane fusion and signal
transduction. The fusion process has been well char-
acterized, yet the role of coreceptor signaling re-
mains elusive. Here, we describe a critical function
of the chemokine coreceptor signaling in facilitating
HIV infection of resting CD4 T cells. We find that
static cortical actin in resting T cells represents a
restriction and that HIV utilizes the Gai-dependent
signaling from the chemokine coreceptor CXCR4
to activate a cellular actin-depolymerizing factor,
cofilin, to overcome this restriction. HIV envelope-
mediated cofilin activation and actin dynamics are
important for a postentry process that leads to viral
nuclear localization. Inhibition of HIV-mediated actin
rearrangement markedly diminishes viral latent in-
fection of resting T cells. Conversely, induction of
active cofilin greatly facilitates it. These findings
shed light on viral exploitation of cellular machinery
in resting T cells, where chemokine receptor signal-
ing becomes obligatory.
INTRODUCTION
HIV replication in humans is now thought to utilize two CD4 cor-
eceptors, CCR5 and CXCR4 (Berger et al., 1999). CCR5 is ex-
pressed on the activated, memory T cells (Bleul et al., 1997)
and appears critical for in vivo susceptibility to infection (Liu
et al., 1996). The efficient infection of activated T cells by
CCR5 virus is in contrast to the metabolic restrictions of
CXCR4 (X4) HIV infection of resting T cells in vitro (Spina et al.,
1997), and yet in nearly one-half of the HIV-infected population,
there is a conversion late in the disease to CXCR4 utilization, cor-782 Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc.responding to an accelerated drop in T cell numbers (Fenyo
et al., 1988). The unexpected potential for the X4 HIV to expand
is borne out by the demonstration of in vivo and ex vivo X4 HIV
infection of resting naive T cells (Eckstein et al., 2001; Nishimura
et al., 2005; Ostrowski et al., 1999). However, an appreciation of
any role of CXCR4, beyond binding and fusion, is lacking.
In vitro, X4 HIV infection of resting T cells is a slow process that
can lead to latency with the potential for productive infection
(Zack et al., 1990). There is evidence that the ability of HIV to es-
tablish latency in resting T cells, albeit slowly, is not purely pas-
sive. HIV may alter the cellular environment to facilitate infection
and subsequent viral production. For example, expression of Nef
in resting T cells can lower the threshold of T cell activation, in-
creasing the likelihood that productive viral replication occurs
(Fenard et al., 2005; Schrager and Marsh, 1999; Wu and Marsh,
2001).
During HIV infection, the virus has to undergo entry, uncoating,
reverse transcription, and nuclear localization. It is unclear
whether these early processes also requiremodulation of cellular
environment by the virus. In particular, at the earliest step, viral
binding to the cellular receptors has the potential to trigger crit-
ical signaling that may favor viral replication (Cicala et al., 2002).
Thus, we tested possible requirements for receptor signaling,
both fromCD4 and fromCXCR4, in viral latent infection of resting
T cells. In this article, we report that signal transduction from the
chemokine coreceptor CXCR4, but not CD4, is required for HIV
latent infection of resting T cells. We also report that the static
cortical actin in noncycling, resting T cells is a postentry barrier
for HIV. To overcome this restriction, the virus utilizes enve-
lope-CXCR4 signaling to activate cofilin, a cellular actin-depoly-
merizing factor critical for actin dynamics and viral nuclear
migration. This cofilin restriction is unique to resting T cells be-
cause in transformed or activated T cells cofilin is constitutively
active, rendering CXCR4 signaling unnecessary (Alkhatib et al.,
1997; Cocchi et al., 1996). Our data uncovered a previously
underappreciated ability of HIV in exploiting the chemokine
coreceptor to meet a fundamental need to interact with the actin
cytoskeleton (Naghavi et al., 2007). Cofilin activation may con-
tribute to viral infection of resting CD4 T cells in vivo.
RESULTS
Critical Signaling Function of CXCR4 in HIV Infection
of Resting CD4 T Cells
To test possible requirements for receptor signaling, both from
CD4 and from CXCR4, in viral infection of resting T cells, we pre-
treated cells with inhibitors. The chemokine coreceptor CXCR4
is coupled to G protein, Gai, which can be uncoupled by treat-
ment with pertussis toxin (PTX). On the other hand, the CD4
Figure 1. Requirement of CXCR4 Signaling
for HIV Infection of Resting CD4 T Cells
(A–H) Inhibition of HIV infection by pertussis toxin
(PTX). Cells were treated with PTX, damnacanthal
(Dam), piceatannol (Pic) or, as controls, medium or
DMSO and were then infected, washed, cultured
for 5 days, and finally activated with anti-CD3/
CD28 beads (A). Shown is viral replication mea-
sured by p24 release (B and C). For comparison,
cells were infected first, treated with these re-
agents, washed, and then cultured and activated
as above (E and F). Cells were also cultured in
IL-2 or IL-7 for 4 days, treated with PTX, infected,
cultured with cytokines, and then activated as
above (G and H).
(I) Enhancement of HIV infection by gp120. Cells
were prestimulated with gp120IIIB, infected, incu-
bated, and then activated.
(J) Enhancement of HIV infection by anti-CD4/
CXCR4 beads. Cells were prestimulated with
anti-CD4/CXCR4, anti-CD4, or anti-CXCR4
beads, infected, incubated, and then activated.
(K and L) Enhancement of HIV replication by anti-
CD4/CXCR4 beads in cytokine-stimulated cells.
Cells were cultured in IL-2 or IL-7 for 4 days, pres-
timulated with anti-CD4/CXCR4 beads, infected,
washed, and then cultured in cytokines.
(M) HIV dosage-dependent enhancement of viral
infection by anti-CD4/CXC4 beads. Cells were
prestimulated with anti-CD4/CXCR4 beads, in-
fected, washed, incubated, and then activated.
receptor is directly coupled with the Src
family tyrosine kinase Lck, which can
be inhibited by damnacanthal. Resting
T cells were briefly treated with these in-
hibitors, infected with HIV, washed, and
incubated for 5 days. During this incuba-
tion, productive viral replication does not
occur. However, viral replication remains
inducible upon T cell activation (Wu and
Marsh, 2001). We activated infected cells
at day 5 with CD3/CD28 stimulation and
observed inhibition of HIV replication by
PTX (Figures 1A and 1B and Figure S1
available online). In contrast, treatment
with PTX after infection was not inhibitory
(Figures 1D and 1E), excluding the possi-
bility that the PTX inhibition was purely a result of PTX-mediated
general toxicity to resting T cells. The slight stimulatory effect of
PTX treated after infection could result from the stimulating effect
of the B-oligomer of PTX on T cell activity (Gray et al., 1989). In
contrast to PTX, damnacanthal did not inhibit viral replication
(Figures 1C and 1F). Additionally, piceatannol, an inhibitor target-
ing the Lck downstreamSyk tyrosine kinase ZAP-70, also did not
inhibit viral replication (Figures 1C and 1F). These data suggest
that signaling from CXCR4, rather than CD4, is important for viral
infection of resting T cells. Furthermore, replacement of the viral
envelope with the CD4/CXCR4-independent VSV-G envelope
avoided the PTX inhibition (Figure S2), demonstrating that theCell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc. 783
signaling requirement is indeed associated with the HIV enve-
lope. We also tested eight primary X4 HIV isolates, and all of
them demonstrated a requirement for CXCR4 signaling (Fig-
ure S3). The inhibition of HIV infection by PTX, as we describe
here, is unique to resting T cells, since PTX treatment of trans-
formed or activated T cells did not inhibit HIV replication
(Figure S4) (Alkhatib et al., 1997; Cocchi et al., 1996).
Resting T cells circulate between peripheral blood and lym-
phoid tissues. To determine whether stimulation of resting
T cells with lymphatic cytokines can alleviate the viral require-
ment for CXCR4 signaling (Kreisberg et al., 2006), we cultured
resting T cells with IL-2 or IL-7 and observed PTX inhibition of
viral replication (Figures 1G and 1H), suggesting that CXCR4
signaling could potentiate infectivity even in certain cytokine-en-
riched microenvironment such as lymphoid tissues (Figure S5).
To further confirm that binding of HIV envelope to resting
T cells triggers positive signaling to facilitate infection, we pre-
stimulated cells with the T-tropic gp120. We speculated that
this stimulationwould provide synergywith theHIV envelope.We
found that at low concentrations (0.5 to 5 nM), gp120 enhanced
HIV replication (Figure 1I and Figure S6). However, at concentra-
tions above 50 nM, gp120 inhibited HIV, presumably because of
competition and downmodulation of CD4 and CXCR4 as previ-
ously described (Figure S7). We further tested whether binding
of CD4 and CXCR4 was directly responsible for the observed
gp120 enhancement, since T-tropic gp120 appears to have
high nonspecific binding to the cell surface (Babcock et al.,
2001). We used beads conjugated with monoclonal antibodies
specific for these receptors. Again, we observed enhancement
of viral replication by stimulation with anti-CD4/CXCR4 or anti-
CXCR4 beads but not with anti-CD4 beads (Figure 1J). These
data are consistent with the inhibition of viral replication by the
CXCR4 inhibitor PTX but not by the CD4 inhibitor damnacanthal
or piceatannol (Figures 1B and 1C), suggesting that CXCR4
alone is largely responsible for the delivery of the signal impor-
tant for viral latent infection. The CD4/CXCR4 enhancement
was observed across multiple donors (Figure S8) and also in cy-
tokine-stimulated CD4 T cells (Figures 1K and 1L). The enhance-
ment was most dramatic at low viral dosages (Figure 1M), sug-
gesting that HIV may rely on synergistic engagements of its
receptors to fulfill a signaling requirement. The enhancement
was neither a result of CD4/CXCR4 stimulation synergizing
with that of CD3/CD28 (Figure S9) nor an effect of gp120-in-
duced T cell activation (Figure S10).
To identify possible viral processes that are sensitive to PTX
and thus require CXCR4 signaling, we first examined the effects
of PTX treatment on viral receptors and receptor-mediated fu-
sion. PTX treatment did not affect surface CD4/CXCR4 expres-
sion (Figure S11) or prevent fusion, although there was a slight
decrease (1.7% to 1.4%, Figure 2A). At a lowmultiplicity of infec-
tion (0.02 TCID50 per cell, measured on Rev-CEM) (Wu et al.,
2007), viral DNA synthesis peaked at 2 days (Zhou et al.,
2005), and PTX did not affect the peak level of viral DNA
(Figure 2B). Along with the fusion experiments, these results
indicate that entry or reverse transcription is not the process dis-
playing PTX sensitivity. We then examined viral DNA nuclear tar-
geting. A sizable fraction of viral DNA migrated into the nucleus
as early as 2 hr (Figure 2C), immediately after signaling events784 Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc.triggered by gp120. In contrast, in PTX-treated cells, viral DNA
nuclear migration was decreased (Figure 2C). This was con-
firmed again by the examination of the viral nuclear DNA at day
3. Although the total viral DNA was similar, the nuclear DNA
was less in PTX-treated cells (Figures 2B and 2D). This is consis-
tent with a measurable decrease of 2-LTR circles (Figure 2E).
Since CD4/CXCR4 stimulation enhanced viral replication
(Figure 1J), we also followed viral processes in stimulated cells.
We observed that early, transient viral DNA synthesis (2 hr) was
enhanced by CD4/CXCR4 stimulation (Figure 2F). This enhance-
ment did not result from an increase in fusion (Figure 2A) but may
occur at a postentry step such as uncoating, reverse transcrip-
tion, or nuclear import. Indeed, viral nuclear migration was
enhanced in CD4/CXCR4-stimulated cells (Figure 2G). Interest-
ingly, in CD4/CXCR4-stimulated cells, the kinetics of viral DNA
synthesis and decay was altered. Although the viral DNA synthe-
sis at day 2 was similar, there was no decrease of viral DNA at
day 3 in CD4/CXCR4-stimulated cells. Fractionation of the nu-
clear DNA at day 3 also revealed that viral nuclear DNA was
increased in the stimulated cells (data not shown). The increased
amount of nuclear DNA also correlated with higher levels of
2-LTR circles and viral integration (Figures 2H and 2I). These
data demonstrate that CD4/CXCR4-stimulation promotes viral
DNA nuclear localization and further suggest that nuclear migra-
tion may subvert the viral DNA decay process. In unstimulated
resting T cells, the viral DNA synthesized at day 2 was largely
diminished after day 3 (Figure 2F). This may result from a lack
of nuclear migration signaling in the absence of continual
CXCR4 stimulation after removal of the input virus. We conclude
that in addition to the functions of viral binding and entry, CXCR4
serves to contribute signaling that is critical for viral DNA nuclear
migration. It is reasonable that this results in an inherent increase
in HIV DNA stability in resting T cells.
HIV Envelope-CXCR4 Signaling Promotes
Cortical Actin Dynamics
In T cells, signaling through CXCR4 leads to chemotactic T cell
motility and actin polymerization (Sotsios et al., 1999). Given
that gp120 has the capacity to trigger signaling through
CXCR4, we examined the possible effects of gp120 on the actin
cytoskeleton of resting T cells. We observed that treatment of
resting T cells with gp120, HIV, or anti-CXCR4 beads triggers
the polymerization and depolymerization of the cortical actin fil-
aments (F-actin) (Figures 3A, 3C, and 3G and Figures S12–S16).
Although localized cortical actin polymerization by gp120 or HIV
was occasionally seen within 1 min of stimulation (Balabanian
et al., 2004) (Figures 3E and 3F and Figures S12–S16), actin
depolymerization was the most consistent observation, and it
usually occurred after 5 min and became more pronounced at
1 to 2 hr (Figures 3A and 3C). As a control, stimulation with
SDF-1, the natural ligand of CXCR4, also triggers rapid, polarized
cortical actin polymerization (Balabanian et al., 2004) (Figures 3B
and 3F). However, for HIV or gp120, at the low dosages we used,
it was generally not capable of triggering such a drastic, global
cytoskeletal rearrangement as was SDF-1. The gp120-mediated
actin change was observed in multiple donors and across a
range of gp120 concentrations tested, from 5 pM to 50 nM
(Figure 3A and Figure S12), and was seen with multiple primary
gp120 and HIV isolates (Figure S16). Replacement of gp120 with
the VSV-G envelope abolished the ability of HIV to trigger actin
changes (Figure S17). Furthermore, depletion of Nef (Campbell
et al., 2004) from the virion particles did not prevent gp120-me-
diated actin depolymerization (Figure S18). These data confirm
that gp120 alone was largely responsible for modulating F-actin.
Other virion factors such as Nef likely act at the post fusion steps
(Tobiume et al., 2003). The decrease in F-actin in response to HIV
or gp120 stimulation did not result from a global loss of the actin
protein (Figure S19). Cellular fractionation of F-actin and globular
actinmonomer (G-actin) further confirmed changes in the ratio of
F-actin to G-actin in response to gp120 treatment (Figure S20).
Actin polymerization inducedbySDF-1 is regulated through the
activation of G proteins, particularly the PTX-sensitive Gai (Sot-
sios et al., 1999). Similarly, gp120-mediated actin depolymeriza-
tion was also found to be mediated through Gai (Figures 3C and
3D). The fact that PTX inhibited both viral replication and actin
Figure 2. Molecular Characterization of
Viral Processes that Require CXCR4
Signaling in Resting CD4 T Cells
(A) Effects of PTX and anti-CD4/CXCR4 stimula-
tion on viral fusion. Cells were treated with PTX
or with anti-CD4/CXCR4 beads, infected with
HIV(BlaM-Vpr) or not infected (Mock), washed,
and then loaded with CCF2 for flow cytometry.
(B) Effects of PTX on viral DNA synthesis. Cells
were treated with PTX and infected. Viral DNA
synthesis was measured by real-time PCR (three
measurements with standard error). Azidothymi-
dine (AZT) was used as a control.
(C and D) PTX Inhibition of viral DNA nuclear local-
ization. Cells were treated with PTX, infected for
2 hr, washed, lysed, and then fractionated into
cytoplasmic and nuclear fractions. DNA was
amplified for HIV late DNA, nuclear b-actin pseu-
dogene, or an exogenously added plasmid as
fractionation controls (C). Nuclear DNA in cells at
day 3 was also measured by real-time PCR (D).
(E) A real-time PCR measurement of 2-LTR circles
in cells at day 8.
(F) Effects of CD4/CXCR4 stimulation on viral DNA
synthesis. Cells were stimulated with anti-CD4/
CXCR4 beads and infected. Viral DNA synthesis
was measured by real-time PCR.
(G) Enhancement of viral DNA nuclear localization
by CD4/CXCR4 stimulation. Cells were stimulated
with anti-CD4/CXCR4 beads, infected for 2 hr, and
then fractionated into cytoplasmic and nuclear
fractions. Viral DNA was measured by real-time
PCR. The average ratio of viral nuclear to cytoplas-
mic DNA in unstimulated control was arbitrarily
assigned as ‘‘1.’’
(H and I) A real-time PCR measurement of 2-LTR
circles (H) and viral DNA integration (I) in cells at
day 8.
change suggests that promotion of actin
dynamics could be one of the essential
functions of gp120-CXCR4 signaling in
primingviral infectionandnuclear localiza-
tion (Figures 1B, 2C, and 3D). It is possible
that in the absence of cell-cycle or chemotactic stimulation, the
cortical actin in resting T cells could be relatively static and repre-
sent a restriction for the virus. As such, increase of cortical actin
activity might be required to achieve intracellular migration of
HIV. It has been known that actin-based motility is critical for the
movement of a variety of intracellular pathogens such as Listeria
monocytogenes, Shigella flexneri, and vaccinia virus. Most of
these pathogens encode molecular mimics such as ActA, VirG,
and A36R to promote actin dynamics (Cameron et al., 2000).
Viral Requirement for Actin Reorganization
in Resting CD4 T Cells
To further address the requirement of actin reorganization for
infection of resting T cells, we used an F-actin stabilizing agent,
jasplakinolide (Jas), to interfere with gp120-induced actin
change. Jas binds to F-actin irreversibly and prevents depoly-
merization of actin filaments. We speculated that Jas couldCell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc. 785
affect HIV latent infection through direct inhibition of actin
change. We observed complete inhibition of HIV replication by
Jas at 120 nM or higher concentrations and partial inhibition at
24 nM (Figure 4A). Jas inhibition was observed across multiple
donors, although there were donor-dependent variations in the
degree of inhibition at low Jas dosages (data not shown).
The inhibition of viral replication by 120 nM and 24 nM Jas was
neither a result of inhibition on T cell activation (Figures S21–S23)
nor an effect of altered CD4/CXCR4 receptor distribution
(Figure S24) that prevented fusion (Figure 4B, only a slight de-
crease from 1.7% to 1.2%). A time-course analysis of viral
DNA synthesis found that 120 nM Jas persistently inhibited viral
DNA synthesis (Figure 4C). DNA fractionation further demon-
strated that the viral nuclear DNA was diminished (Figure 4D).
These data suggest that binding of Jas irreversibly to F-actin
may competitively inhibit viral association with F-actin and thus
inhibits viral reverse transcription and nuclear migration. These
findings are consistent with an earlier proposal that establish-
ment of the viral reverse transcription complex is dependent
on contact with actin microfilaments (Bukrinskaya et al., 1998).
The Jas inhibition on actin rearrangement could be obviated
by T cell activation because similar 120 nM Jas treatment of
transformed or activated T cells (Figures S25 and S26A) did
not inhibit HIV replication. It is likely that at 120 nM, Jas does
not inhibit the cell cycle or cell-cycle-mediated actin remodelling;
thus, new actin filaments generated may be free of Jas. At
a higher dosage (3 mM), however, when the cell cycle was
Figure 3. HIV Envelope-CXCR4 Signaling Promotes
Cortical Actin Dynamics
(A and B) Actin changes mediated by gp120 or SDF-1. Cells
were treated with gp120IIIB or SDF-1, fixed, permeabilized,
and then stained with FITC-phalloidin for flow cytometry.
(C and D) HIV-mediated actin depolymerization was depen-
dent on PTX-sensitive Gai signaling. Cells were not treated
(C) or treated with PTX (D) for 2 hr, infected, and then stained
with FITC-phalloidin.
(E and F) Confocal microscopy of FITC-phalloidin staining of
cells treated with gp120IIIB, SDF-1, HIV or PTX plus HIV. The
full time courses of these treatments are shown in Figures
S12 toS14. Red arrows indicate localized actin polymerization.
(G) Actin depolymerization triggered by stimulation of CXCR4.
Cells were stimulated with either anti-CD4 or anti-CXCR4-
IMag particles, and stained with FITC-phalloidin.
arrested, Jas did inhibit HIV replication in cycling
T cells (Figure S26B). Additionally, CD4/CXCR4
prestimulation of resting T cells also completely
abolished the inhibition by 120 nM Jas (Figure S27),
likely as a result of increased actin dynamics,
prompted by CD4/CXCR4 stimulation.
To further confirm that the static actin cytoskele-
ton in unstimulated resting T cells constitutes a re-
striction for HIV, we used another actin modulator,
Latrunculin A (Lat-A), which has been shown to
specifically induce actin depolymerization through
reversible binding to G-actin. We speculated that
induction of actin depolymerization by Lat-A may
enhance HIV replication if the cortical actin is rela-
tively static and serves as a barrier. To test this hypothesis, we
first titrated Lat-A at various dosages and found that at high dos-
ages (2.5 mM to 250 nM), Lat-A induced dramatic actin depoly-
merization, whereas at a lower dosage (25 nM) it induced actin
depolymerization to an extent similar to that induced by HIV
(Figure 4E). Thus, we pretreated resting T cells with 25 nM
Lat-A and consistently observed enhancement of HIV replication
in all donors examined (Figure 4F). We also tested Lat-A at higher
dosages where Lat-A-induced actin depolymerization was
much greater than the physiological depolymerization induced
by HIV (Figure 4E). Interestingly, at 250 nM, we observed do-
nor-dependent variations from enhancement to inhibition (data
not shown). At 2.5 mM, however, Lat-A inhibited viral replication
in all donors (Figure 4G). These data imply that excessive, non-
physiological depolymerization may affect T cell function or viral
activity. Nevertheless, our data conclusively demonstrate that
irreversible stabilization of actin by Jas inhibits HIV replication,
whereas slight depolymerization of actin by Lat-A enhances viral
replication. Collectively, these findings suggest that the static
actin cytoskeleton in resting T cells represents a barrier that
needs to be dynamically reorganized, and HIV may exploit the
CXCR4 signaling pathway to fulfill this requirement.
HIV Envelope-CXCR4 Signaling Triggers Activation
of Cofilin to Promote Actin Dynamics
In eukaryotic cells, assembly and disassembly of actin fila-
ments are modulated primarily by cofilin, a member of the786 Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc.
actin-depolarizing factor (ADF) family of proteins (Bamburg et al.,
1980). The most important physiological function of cofilin is to
sever and depolymerize actin filaments, thereby promoting actin
dynamics (Lappalainen and Drubin, 1997). Cofilin activity is
regulated by phosphorylation at serine 3, which prevents the
association of cofilin with actin (Arber et al., 1998), whereas
dephosphorylation by phosphatases activates cofilin (Ambach
et al., 2000; Gohla et al., 2005; Niwa et al., 2002). Given that
HIV envelope-CXCR4 signaling mediates actin depolymeriza-
tion, we examined cofilin activity in resting T cells and in cells in-
fected with HIV. We observed that in resting T cells, cofilin was
largely inactivated by phosphorylation, and upon HIV infection,
cofilin was activated by dephosphorylation within minutes
(Figure 5A). HIV-induced cofilin activation in resting T cells was
Figure 4. Viral Requirement for Actin Activ-
ity in HIV Infection of Resting CD4 T Cells
(A) Jas inhibition of HIV infection. Cells were
treated with Jas for 2 hr, washed, infected,
washed, cultured, and then activated with anti-
CD3/CD28 beads to initiate viral replication.
(B) Effects of Jas on viral fusion. Cells were treated
with 120 nM Jas, infected with HIV(BlaM-Vpr),
washed, and then loadedwith CCF2 for measuring
fusion.
(C) Effects of Jas on viral DNA synthesis. Cells
were treated with 120 nM Jas for 1 hr and infected.
Viral DNA synthesis was measured by real-time
PCR. AZT was used as a control.
(D) Inhibition of viral DNA nuclear localization by
120 nM Jas. Cells were treated with 120 nM Jas,
infected, washed, lysed, and then fractionated
into cytoplasmic and nuclear fractions as in
Figure 2C.
(E) Dosage- and time-dependent actin depolymer-
ization by Lat-A. Cells were treated with Lat-A for
5 min (left panel) or with 25 nM Lat-A for various
times (right panel) and stained with FITC-phalloi-
din for flow cytometry. Untreated and HIV-infected
cells were used as controls.
(F) Enhancement of HIV infection by Lat-A. Cells
were treated with 25 nM Lat-A for 5 min, washed,
infected, washed, cultured, and then activated. As
a control, cells were also infected first, washed,
treated with Lat-A for 5 min, washed, and then
incubated and activated identically.
(G) Dosage-dependent effects of Lat-A on HIV
infection. Cells were treated with Lat-A for 5 min
at different dosages, infected, washed, incubated,
and then activated.
seen in all donors examined and with
multiple primary isolates of HIV (Fig-
ure S28A). Moreover, the kinetics corre-
lated well with HIV-induced actin depoly-
merization, with strong cofilin activation
and actin depolymerization occurring
between 1 and 2 hr (Figure 3C). Occa-
sionally, we observed quick actin poly-
merization within 1 min (Figure S13), and
this correlated with a transient increase
in cofilin phosphorylation within 1 min and was then followed
by cofilin dephosphorylation and activation (data not shown).
Cofilin activation was further observed by treatment of resting
T cells with gp120 (Figure 5B) or anti-CXCR4 beads (Figure 5C)
but not with anti-CD4 beads (Figure 5D), demonstrating that en-
gagement of CXCR4 is sufficient to activate cofilin. Furthermore,
pretreatment of resting CD4 T cells with a highly specific CXCR4
antagonist, AMD3100 (Gerlach et al., 2001), or PTX completely
inhibited cofilin activation by HIV (Figures 5E–5H and
Figure S28B). This is consistent with PTX inhibition of actin depo-
lymerization by HIV (Figure 3D). On the basis of these data, we
conclude that HIV envelope binding to CXCR4 triggers PTX-
sensitive activation of cofilin and its association with F-actin
(Figure S29) to promote actin dynamics.Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc. 787
Contrary to resting T cells, activated or transformed T cells do
not require CXCR4 signaling to support viral replication. It is pos-
sible that in these cells cofilin is differently regulated (Samstag
et al., 1994). Indeed, when the ratio of phospho-cofilin to active
cofilin was compared, transformed or activated T cells predom-
inantly carried dephosphorylated, active cofilin (Figures 5I and
5J), suggesting that T cell activation promotes cofilin activity,
rendering CXCR4 signaling unnecessary for HIV. Unlike T cell ac-
tivation, stimulation of resting T cells with cytokines such as IL-2
and IL-7 did not activate cofilin (Figure 5K), and consistently, the
presence of these cytokines did not alleviate the requirement for
CXCR4 signaling (Figures 1G and 1H). We conclude that cofilin
Figure 5. HIV Envelope-CXCR4 Signaling Triggers
PTX-Sensitive Activation of Cofilin
(A–D) Activation of cofilin by HIV, gp120 or CXCR4 stimulation.
Cells were treated with HIV (A), gp120 IIIB (B), anti-CXCR4
beads (C), or anti-CD4 beads (D), and then analyzed by West-
ern blot using an anti-phospho-cofilin antibody (P-cofilin). The
blots were stripped and reprobed with an antibody against
total cofilin.
(E and F) AMD3100 inhibits gp120-triggered cofilin activation.
Cells were not treated (E) or treated with AMD3100 (F), stimu-
lated with gp120, and then analyzed by western blot.
(G, H) PTX-sensitive activation of cofilin by HIV. Cells were not
treated (G) or treated with PTX (H), infected, and then analyzed
by Western blot.
(I) Constitutive activation of cofilin in transformed cell lines.
P-cofilin (upper band) and active cofilin (lower band) were sep-
arated and detected by NEPHGE-western blot using an anti-
cofilin antibody. The relative ratio of P-cofilin to active cofilin is
indicated at the bottom.
(J) Cofilin activation induced by PHA plus IL-2 treatment of
resting T cells. HIV-infected cells were used as a control. Cells
were analyzed by NEPHGE-western blot.
(K) IL-2 or IL-7 stimulation does not activate cofilin. Resting
T cells were stimulated with IL-2 or IL-7, and then analyzed
by western blot.
(L–Q) shRNA knockdown of cofilin in CD4 T cells. Knockdown
procedure is in Figure S31. Cells carrying cofilin shRNA or
a control shRNA (NTC) were analyzed by western blot with
an anti-human cofilin antibody or an anti-human GAPDH anti-
body (L). Suppression of cofilin expression leads to an accu-
mulation of F-actin as measured by FITC-phalloidin staining
and analyses with flow cytometry or confocal microscopy
(M and N). (O) shows a real-time PCR measurement of viral
DNA synthesis in knockdown cells. (P) shows a real-time
PCR measurement of HIV 2-LTR circles in knockdown
cells at 12 hr (left panel) and 24 hr (right panel) post infection.
(Q) shows a RT-PCR analysis of the same cells at 12 hr,
measuring HIV nef and the cellular GAPDH transcripts.
activation is a unique event occurring in HIV infec-
tion of resting T cells or cells exposed to certain
cytokines.
To further determine the requirement for cofilin
activity in HIV-mediated actin change and viral
infection, we suppressed cofilin expression to
approximately two-thirds in CD4 T cells, utilizing
small interfering RNA (siRNA) (Figure 5L and
Figure S31E). The cofilin knockdown cells demon-
strated significantly higher levels of cortical actin
filaments (Figures 5M and 5N and Figures S31F and S31G), in
agreement with our results showing that induction of cofilin activ-
ity by gp120, an inverse of cofilin suppression, led to the depoly-
merization of F-actin (Figures 3A, 3C, 5A, and 5B). The cofilin
knockdown cells also displayed a diminished capacity to sup-
port HIV replication (Figure S31H). However, given that cofilin
is a fundamental protein involved in multiple cellular processes,
the inhibition on viral replication may not be viral specific.
Thus, we directly examined viral early processes after infection.
We found a higher level of total viral DNA early after infection of
the cofilin knockdown cells (Figure 5O), suggesting that fusion,
entry, and reverse transcription were not adversely affected.788 Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc.
However, viral 2-LTR circles were decreased by approximately
2.5- and 3-fold at 12 and 24 hr (Figure 5P), suggesting a decrease
of viral DNA nuclear migration in the cofilin knockdown cells. If
normalized to total viral DNA, the cofilin knockdown cells had
an approximate 90% reduction in nuclear viral DNA at 12 hr, in
comparison with the control. Quantification of viral early tran-
scripts at 6 and 12 hr also showed that the nef transcript was de-
creased (Figure 5Q), a confirmation of diminished viral nuclear
DNA templates available in the cofilin knockdown cells. On the
basis of these data, we conclude that suppressing cofilin activity
led to an aberrant accumulation of cortical actin and an impedi-
ment to viral nuclear migration. This is consistent with a viral re-
quirement for CXCR4 signaling and cofilin activation to mediate
cortical actin change for nuclear migration. The mechanism for
the early increase in total viral DNA in cofilin knockdown cells
is unknown, but it could result from possible stimulatory effects
of F-actin to viral transcriptional process (Bukrinskaya et al.,
1998; De et al., 1993; Hottiger et al., 1995).
Cofilin Activation Promotes HIV Latent Infection
of Resting CD4 T Cells
As an alternative approach to confirm the role of cofilin in HIV in-
fection, we also pursued modulation of cofilin activity by altering
upstream signals. In resting T cells, cofilin is inhibited by phos-
phorylation at serine-3. The inhibition is maintained through the
basal activity of the LIM family protein kinases (LIMK), for which
cofilin proteins are the only known substrates (Arber et al., 1998).
To date, there is no known specific inhibitor for LIM kinases. To
test whether activation of cofilin is directly involved in viral latent
infection, we used a synthetic peptide to compete with cofilin for
LIMK1 to inhibit cofilin phosphorylation. This peptide, S3, carries
the N-terminal 16 residues, including serine 3 of human cofilin
(Nishita et al., 2002) (Figure 6A). In an in vitro LIMK1 kinase assay,
we observed that S3 directly inhibited cofilin phosphorylation by
LIMK1 (Figure 6B).We next testedwhether activation of cofilin by
S3 would enhance viral latent infection. We observed enhance-
ment of viral replication by S3 (Figures 6C–6E), and this enhance-
ment did not result from enhancement on T cell activation
through CD3/CD28 stimulation (Figure S32).
In addition to S3, we have also testedmultiple kinase inhibitors
to probe HIV-mediated signaling in resting T cells (Figure 1). Of
these, we observed that staurosporine, a general serine/threo-
nine kinase inhibitor, yielded an unexpected result. Although
this inhibitor largely shuts down T cell activation (Kubbies
et al., 1989) (Figure S33), the transient treatment of resting
CD4 T cells with staurosporine prior to infection, but not after-
wards (Figure S34), led to a dramatic enhancement in HIV repli-
cation (Figure 7A). Given the broad impact of staurosporine on
cell signal transduction, we felt compelled to examine possible
effects of this general kinase inhibitor on cofilin activation. We
found that the brief treatment of resting CD4 T cells with stauro-
sporine led to gradual dephosphorylation and activation of cofilin
in the absence of any stimulation (Figure 7B). With the activation
of cofilin, actin depolymerization was also observed in stauro-
sporine-treated cells (Figure 7C). These features remarkably re-
semble those initiated by HIV infection of resting T cells (Figures
3C and 5A). Within the cofilin pathway, staurosporine appears to
act on LIMK1-mediated cofilin phosphorylation directly, sincethe kinase activity assay showed that staurosporine strongly de-
creased the phosphorylation of cofilin by LIMK1 (Figure 7D).
Thus, the unexpected ability of staurosporine to activate cofilin
and enhance viral replication, through transient exposure before
infection, appears consistent with the identified role of cofilin in
HIV infection.
Collectively, our data demonstrate that activation of cofilin is
one of the most important events in HIV latent infection of resting
T cells. Because the chemokine receptor signaling is diverse, we
do not exclude other possible functions of the chemokine
Figure 6. Induction of Cofilin Activation by S3 Peptide Promotes
Viral Latent Infection of Resting CD4 T Cells
(A) Human nonmuscle cofilin protein sequence. The sequence of S3 is shown
in the boxed region, and serine 3 is denoted with an asterisk.
(B) S3 activates cofilin through competitive inhibition of LIMK1. An in vitro LIMK
kinase assay was performed with purified LIMK1 and GST-tagged recombi-
nant human cofilin in the presence of S3, S3D, or Q104. Cofilin phosphoryla-
tion was analyzed by western blot.
(C–E) Enhancement of viral replication by S3. Cells were treated with S3, S3D,
or Q104 for 2 hr, infected, washed, cultured, and then activated to initiate viral
replication. (E) shows a S3 dosage-dependent enhancement of viral replica-
tion at day 8.Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc. 789
receptor signaling in facilitating HIV infection in the various
cellular states found in vivo.
DISCUSSION
Here, we report that HIV-mediated CXCR4 signaling actively
takes part in an early postentry step, specifically, nuclear locali-
zation, for the latent infection of resting T cells. We also identify
the targetedmolecular activity of CXCR4 signaling, the activation
of cofilin. Although it is straightforward to envision that the corti-
cal actin in resting cells is a barrier to nuclear import, the suc-
cessful delivery of the preintegration complex to the nucleus
likely depends on other cytoskeletal functions. Indeed, another
cytoskeletal factor, moesin, has been shown recently to directly
influence retroviral infectivity (Naghavi et al., 2007), and impor-
tant interactions between the viral components and the cellular
cytoskeleton have been previously documented; retroviruses
may use the actin cytoskeleton to facilitate transfer of viral ge-
nome from the peripheral regions of the cell to the microtubule
network for reverse transcription and postentry migration (Buk-
rinskaya et al., 1998; McDonald et al., 2002; Naghavi et al.,
2005). The viral nucleocapsid (Wilk et al., 1999), reverse tran-
scriptase (Hottiger et al., 1995), and integrase (Turlure et al.,
2004) have been known to directly interact with actin, suggesting
Figure 7. Induction of Cofilin Activation by Stauro-
sporine Promotes Viral Latent Infection of Resting
CD4 T Cells
(A) Enhancement of viral replication by staurosporine. Cells
were treated with staurosporine for 2 hr, infected, washed,
incubated, and then activated to initiate viral replication.
(B) Staurosporine induces cofilin activation in resting T cells.
Cells were treated with staurosporine and analyzed by west-
ern blot.
(C) Staurosporine induces actin depolymerization in resting
T cells. Cells were treated with staurosporine and stained
with FITC-phalloidin for flow cytometry.
(D) Staurosporine induces cofilin activation by direct inhibition
of LIMK1. An in vitro LIMK kinase assay was performed in the
presence or absence of staurosporine.
(E) Model of gp120-CXCR4 signaling in mediating cofilin acti-
vation and HIV latent infection. Binding of gp120 to CXCR4
triggers fusion and signal transduction that leads to cofilin ac-
tivation. After fusion, the viral preintegration complex is di-
rectly anchored onto F-actin to facilitate reverse transcription
(Bukrinskaya et al., 1998). Subsequent actin activity mediated
by cofilin activation increases cortical actin dynamics and
actin treadmilling, which promote the movement of the viral
preintegration complex toward the center of the cell.
possible anchorage of the preintegration complex
onto the actin network. Our results also suggest
that the actin cytoskeleton in resting CD4 T cells
may not simply be a barrier, because excessive de-
polymerization of actin by Lat-A inhibits viral repli-
cation (Figures 4E and 4G). It is reasonable that
the direct interaction of the virus with the cortical
actin mass could facilitate uncoating or reverse
transcription or allow HIV to gain access to the
perinuclear and nuclear region (Figure 7E).
We identify cofilin as a critical factor required for HIV latent in-
fection of resting CD4 T cells. Importantly, cofilin is different from
previously identified restriction factors, such as Murr1 (Ganesh
et al., 2003) or the low molecular mass APOBEC3G (LMM
A3G) (Chiu et al., 2005). Although knockdown of Murr1 or LMM
A3G in resting T cells can lead to productive viral replication,
activation of cofilin by gp120, S3, or staurosporine did not. Acti-
vation of cofilin appears to be a naturally evolved function of
gp120 by viral selection of the CXCR4 chemokine receptor.
In the human immune system, cofilin regulates actin dynamics
and is involved in T cell migration and activation (Eibert et al.,
2004; Nishita et al., 2002). It has been known that a genetic de-
fect affecting actin dynamics due to deficiency of WASP causes
immunodeficiency (Symons et al., 1996). It was also predicted
that abnormalities in cofilin or its regulatory molecules could
cause T cell-mediated immunodeficiency (Bamburg and Wig-
gan, 2002). The demonstration of cofilin as a critical target of
the viral envelope suggests that this biochemical pathway in
CXCR4 T cells could be aberrantly altered in HIV infected individ-
uals. Indeed, we have extended our study into HIV-infected
patients. Our preliminary data suggest that in their CD4 T cells,
cofilin activity is aberrantly upregulated (data not shown).
Cofilin is the primary molecule regulating cortical actin dynam-
ics (Lappalainen and Drubin, 1997). In cycling cells, cofilin is790 Cell 134, 782–792, September 5, 2008 ª2008 Elsevier Inc.
constitutively active to facilitate constant remodeling of the actin
cytoskeleton. In contrast, in resting CD4 T cells cofilin is largely
inactive, implying a less dynamic cortical actin that may repre-
sent a realistic barrier for the virus. Activation of cofilin is an
apparent solution, and HIV exploits the chemokine receptor to
meet this fundamental need at the earliest step of its life cycle.
EXPERIMENTAL PROCEDURES
Treatment and Infection of Resting CD4 T Cells
Resting CD4 T cells were purified from peripheral blood as previously de-
scribed (Wu and Marsh, 2001). Cells were treated with pertussis toxin (Sigma),
jasplakinolide (Invitrogen), or staurosporine (Biomol) for 2 hr or latrunculin A
(Biomol) for 5 min and then infected with HIV. For HIV infection, unless spec-
ified, 103.5 to 104.5 TCID50 units (measured on Rev-CEM) (Wu et al., 2007)
were used to infect 106 cells. After infection, cells were washed two to three
times. Cells were treated with synthetic peptide S3 or the control peptides,
S3D or Q104, for 1 to 2 hr before being infected with HIV.
FITC-Phalloidin Staining of F-Actin and Flow Cytometry
Cells were treated with gp120 IIIB (Microbix Biosystems) from 1 min to 2 hr,
fixed, permeabilized, and stained with 5 ml of 0.3 mM FITC-labeled phalloidin
for 30 min at 4C. After being washed, cells were resuspended in 1% parafor-
maldehyde and analyzed on a FACSCalibur (Becton Dickinson).
Measurement of Cofilin and Phospho-Cofilin by Western Blot
Cells were lysed in NuPAGE LDS Sample Buffer (Invitrogen), separated by
SDS-PAGE, transferred onto nitrocellulose membranes (Invitrogen), and
blocked for 30 min with Starting Block buffer (Pierce). The blots were incu-
bated with either a rabbit anti-cofilin antibody (1:1000 dilution) (Cell Signaling)
or a rabbit anti-phospho-cofilin (ser3) antibody (1:1000 dilution) (Cell Signal-
ing). The blots were washed and then incubated with goat anti-rabbit horse-
radish peroxidase-conjugated antibodies (1:1000 dilution) (KPL). The blots
were developed with SuperSignal West Femto Maximum Sensitivity Substrate
(Pierce).
In Vitro LIMK Kinase Assay
A LIMK1 kinase assay was performed with purified LIMK1 and GST-tagged
recombinant human cofilin (Upstate Biotechnologies). In brief, recombinant
cofilin was incubated in 13 Kinase reaction buffer in the presence or absence
of staurosporine or the S3, S3D, Q104 peptides. LIMK1 was serially diluted in
dilution buffer and then added into the reaction along with the ATP buffer. The
reaction was incubated for 15 min at 30C.
SUPPLEMENTAL DATA
Supplemental Data include 34 figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found with this article online
at http://www.cell.com/cgi/content/full/134/5/782/DC1/.
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